Centaura
Company with mission to prevent and reverse aging.
Centaura is an ambitious and industry-defining project aimed at fighting aging. Instead of targeting one single reason why humans grow old, Centaura applies a multi-factor approach to understand the forces driving aging, identify the connections between aging and the onset of chronic health conditions, and develop novel interventions that extend human health and longevity. Centaura’s mission is to prevent and reverse aging, keeping people healthy and functional both cognitively and physically, significantly increasing human life expectancy and dramatically changing the course of human life.
Board members
- João Pedro de Magalhães - Chief Scientific Officer
Scientific Advisory Board
- Brian Kennedy
- Karen Miga
- Vera Gorbunova
- Andrei Seluanov
- Jerry Willial Shay
Visit website: https://centaura.com/
Details last updated 07-Nov-2020
Mentioned in this Resource
João Pedro de Magalhães
Professor of Molecular Biogerontology at University of Birmingham Institute of Inflammation and Ageing, consultant, futurist, speaker
Other people at Centaura
Centaura News
Centaura's human artificial chromosome to treat complex diseases, including ageing
Medium - 10-Sep-2021
A breakthrough technology focusing on effective gene therapies for healthy longevity
Read more...João Pedro de Magalhães discusses longevity pharmacology and importance of human trials
Longevity Technology - 23-Mar-2021
Advances in longevity pharmacology to revolutionize healthcare with personalized therapies
Read more...